Quantification of harms in cancer screening trials: literature review

Bruno Heleno(Universidade Nova de Lisboa), John Brodersen(University of Copenhagen), David Rodrigues(Universidade Nova de Lisboa), Karsten Juhl Jørgensen(University of Southern Denmark), M. F. Thomsen(University of Copenhagen)
BMJ
September 16, 2013
10.1136/bmj.f5334
Cited by 130

Related Papers

The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
|Thorax|2012|391
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
|American Journal of Respiratory and Critical Care Medicine|2015|343
Long-Term Psychosocial Consequences of False-Positive Screening Mammography
|The Annals of Family Medicine|2013|342